Company · CIK 0001856725 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Rani Therapeutics Holdings, Inc. · RANI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2026 PForm 4 → | Jul 23, 4:10 pm EDT | Mir A ImranDirector, 10% Owner | 36,000 | $0.69 | $24,840 | 2,119,334 | +1.73% | |
| Jul 17, 2026 PForm 4 → | Jul 21, 6:29 pm EDT | Talat ImranChief Executive Officer, Director | 35,000 | $0.7198 | $25,193 | 469,736 | +8.05% | |
| Jun 27, 2026 FForm 4 → | Jul 21, 7:24 pm EDT | Alireza JavadiChief Technical Officer | 309 | $0.74 | $229 | 9,380 | — | late |
| Mar 27, 2026 SForm 4 → | Jul 21, 7:24 pm EDT | Alireza JavadiChief Technical Officer | 386 | $0.78 | $301 | 9,689 | −3.83% | late |
| Jun 27, 2025 FForm 4 → | Jul 21, 2026, 6:25 pm EDT | Talat ImranChief Executive Officer, Director | 52,001 | $0.8409 | $43,728 | 434,736 | — | late |
| Dec 27, 2024 SForm 4 → | Jul 21, 2026, 6:25 pm EDT | Talat ImranChief Executive Officer, Director | 8,014 | $1.41 | $11,300 | 486,737 | −1.62% | late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 AForm 4 → | Aug 4, 8:51 pm EDT | Michelle GilsonDirector | 247,200 | — | — | 247,200 | — | |
| Jul 17, 2026 AForm 4 → | Jul 21, 4:51 pm EDT | Nicholas MaestasChief Financial Officer | 2,000,000 | — | — | 2,000,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 6:20 pm EDT | Kate McKinleyChief Business Officer | 805,500 | — | — | 805,500 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 6:17 pm EDT | Alireza JavadiChief Technical Officer | 805,500 | — | — | 805,500 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 6:14 pm EDT | Talat ImranChief Executive Officer, Director | 3,800,000 | — | — | 3,800,000 | — |